HealthcareServices

Personalized Cell Therapy Market Forecast 2026–2035: Data Trends and Industry Insights

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized cell therapy market from 2026–2035 with trusted insights from The Business Research Company

How much is the Personalized Cell Therapy Market valued at in 2026, and what valuation is forecast for 2030?

The personalized cell therapy market has witnessed significant expansion in recent years. Its valuation is anticipated to increase from $20.83 billion in 2025 to $25.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.1%. The growth observed in the historic period can be ascribed to factors including the limited availability of autologous cell therapies, a high dependency on conventional treatments, the lack of advanced biomanufacturing infrastructure, slow regulatory approvals, and low patient awareness of personalized therapies.

The market size for personalized cell therapy is projected to experience rapid expansion in the coming years. By 2030, this market is anticipated to reach $56.46 billion, growing at a compound annual growth rate (CAGR) of 22.1%. This anticipated growth during the forecast period is fueled by several factors, including an escalating demand for both autologous and allogeneic cell therapies, a greater embrace of AI-powered treatment optimization, increased public and private investment in cell therapy research, wider applications across cancer, cardiovascular conditions, and autoimmune diseases, and strengthening collaborations between biotechnology companies and research institutions. Key trends expected over the forecast period encompass a broader acceptance of genomic-based cell therapy methods, a surge in the deployment of personalized immunotherapy strategies, enhanced incorporation of digital platforms for managing cell therapies, greater utilization of AI and big data in cell therapy investigations, and an uptick in investment towards biomanufacturing and scalable cell production.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19137&type=smp

What Drivers Are Influencing The Growth Of The Personalized Cell Therapy Market?

The increasing prevalence of neurological disorders is anticipated to fuel the expansion of the personalized cell therapy market. These disorders encompass conditions impacting the brain, spinal cord, and nerves, resulting in issues such as compromised motor function, cognitive impairments, and sensory problems. Their occurrence is linked to an aging population, environmental pressures, and shifts in lifestyle, which together contribute to a greater frequency of neurodegenerative illnesses. The necessity for personalized cell therapy in addressing neurological disorders stems from its capacity to deliver customized treatments, precisely addressing individual patient requirements, potentially aiding in the regeneration of damaged neural tissue and enhancing results in intricate, unique conditions. As an illustration, an article published in April 2024 by Neurology, a US-based publication of the American Academy of Neurology, indicated that worldwide instances of brain disorders, also referred to as neurological disorders, are predicted to rise by approximately 22% by 2050. Consequently, the surge in neurological disorders is propelling the growth of the personalized cell therapy market.

What Segments Are Included Within The Personalized Cell Therapy Market?

The personalized cell therapy market covered in this report is segmented –

1) By Cell Type: Lymphocytes, Mesenchymal Stem Cells (MSCs), Hematopoietic Stem Cells, Other Cell Types

2) By Technique: Cell Engineering And Expansion Techniques, Bone Marrow Transplantation, Autologous Cell Infusion Techniques, Adoptive Cell Transfer Techniques

3) By Application: Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications

4) By End-User: Hospital, Cell Therapy Treatment Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Lymphocytes: T Cells, Natural Killer (NK) Cells, Regulatory T Cells

2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs, Adipose Tissue-Derived MSCs, Umbilical Cord-Derived MSCs

3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells, Allogeneic Hematopoietic Stem Cells

4) By Other Cell Types: Dendritic Cells, Fibroblasts, Endothelial Cells

How Are New Market Trends Shaping The Landscape Of The Personalized Cell Therapy Market?

Leading companies within the personalized cell therapy market are concentrating on novel treatments such as closed-system sterility, which facilitates the contamination-free processing of patient-derived cells from their initial collection to their ultimate formulation. Closed-system sterility denotes a method of handling cells without exposing them to the external environment, thereby ensuring their sterility throughout the entire manufacturing or handling procedure. For example, in March 2025, Limula SA, a Switzerland-based entity specializing in advanced cell therapy solutions, introduced LimONE, an automated platform for manufacturing cell therapy. This marked a considerable progression aimed at streamlining the creation of personalized treatments including CAR-T and hematopoietic stem cell treatments. Moreover, it delivers a sterile closed-system workflow and more consistent patient-specific cell therapy production.

Who Are The Core Companies Influencing Trends In The Personalized Cell Therapy Market?

Major companies operating in the personalized cell therapy market are Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd, Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc., Bluebird bio Inc., Autolus Therapeutics plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-cell-therapy-global-market-report

Which Regions Are Projected To Dominate The Personalized Cell Therapy Market In The Coming Years?

North America was the largest region in the personalized cell therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Cell Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19137&type=smp

Browse Through More Reports Similar to the Global Personalized Cell Therapy Market 2026, By The Business Research Company

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Autologous Cell Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795